New scientific publication on Mucoprotection and diarrheal processes.

Szajewska H, Kołodziej M, Łukasik J. Drug development and acute gastrointestinal infections. Expert Opin Investig Drugs. 2017 Dec 26:1-6 

Expert Opin Investig Drugs. 2017 Dec 26:1-6.

 

NO ABSTRACT AVAILABLE

Mucoprotectans chapter:

4. Mucosal protective agents

Clarifying the role of intestinal mucus in reducing inflammation and infection has led to the development of ‘mucosal protectors’. These agents form a bioprotective film in the gastrointestinal tract and potentially may prevent microorganisms from crossing the mucus barrier [9]. To date, the best studied substances include xyloglucan (a hemicellulose polysaccharide found in all land plants) and gelatin tannate (a complex of tannic acid, which possesses astringent, antibacterial, and anti-inflammatory properties, and is a protective gelatin). However, data on the efficacy of these two agents are very preliminary.